Canada may be the first G7 country to fully legalize cannabis for recreational use, but when it comes to psychedelics, they still have a long road ahead of them. This month, the country took one step closer to a possible future of legal psychedelics by making psilocybin and MDMA more swiftly available for medicinal use. This can make a world of difference considering the time sensitive needs of terminally ill patients such as Thomas Hartle, the first Canadian to receive approval for psilocybin for end of life anxiety for terminal bowel cancer back in 2020, who is still waiting for his next official approval from the Canadian government.
Share this post
